Zanfina Ademi

MONASH UNIVERSITY

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Jane Fisher

MONASH UNIVERSITY

AUSTRALIA

View details

Jonathan Shaw

AUSTRALIA

View details

David V Pilcher

MONASH UNIVERSITY

AUSTRALIA

View details

Keith Abrams

Professor of Statistics & Data Science

University of Warwick

UNITED KINGDOM

View details

Stanley Luchters

Professor in Population Health and Environment

Liverpool School of Tropical Medicine

UNITED KINGDOM

View details

Daryl Jones

AUSTRALIA

View details

Zhibin Chen

MONASH UNIVERSITY

AUSTRALIA

View details

Kevan Polkinghorne

Prof

Monash Health

AUSTRALIA

View details

Dianna Magliano

Lab Head/ Epidmiologist

Baker Heart and Diabetes Institute

AUSTRALIA

View details

Clara Marquina

MONASH UNIVERSITY

AUSTRALIA

View details

Rachelle Buchbinder

MONASH UNIVERSITY

AUSTRALIA

View details

David Dunstan

Professor

Australian Catholic University

AUSTRALIA

View details

Danny Liew

MONASH UNIVERSITY

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Zanfina Ademi

Research Interests

Explore related searches

Contact this professor

Articles (10)

Considering equity and cost-effectiveness in assessing a parenting intervention to promote early childhood development in rural Vietnam

Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease

Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis

A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus

Estimating Australian hospitalisation ratios and costs for wildtype SARS-CoV-2 in 2020

Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031

Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults

Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review

Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis

Economic Evaluation of the Community Benefit of the Australian Pregnancy Register of Antiseizure Medications

Collaborators (13)

Jane Fisher

Jonathan Shaw

David V Pilcher

Keith Abrams

Stanley Luchters

Daryl Jones

Zhibin Chen

Kevan Polkinghorne

Dianna Magliano

Clara Marquina

Rachelle Buchbinder

David Dunstan

Danny Liew

Make your next move.